Antiviral Agents

    Cards (17)

    • Virus entry:
      • Inhalation - via respiratory tract
      • Ingestion - via GI tract
      • Inoculation - through skin abrasions/mucous membranes/transfusions/injections/transplants
      • Congenital - from mother to foetus
    • Stopping a virus:
      • Host defence mechanisms
      • Humoral
      • Cell-mediated
      • Antiviral agents
      • Inhibition of nucleic acid synthesis
      • Inhibition of viral proteins
      Antiviral agents are still underdeveloped in comparison to antibiotics.
    • Balance of host defence mechanisms:
      • Role of cytokines
      • The activation of host cells such as lymphocytes
      • Lymphocytes such as T or B cells and Natural Killer cells
    • Immuno-stimulation can be achieved by:
      • Administration of human immune globulin
      • Administration of immuno-stimulant drugs
      This is usually done by vaccination
    • Antivirals in dental practice are nucleoside analogues - interfere with replication of viral nucleic acid - therefore more effective the earlier they are prescribed.
    • Antiherpetic agents are predominantly nuceloside analogues - example: aciclovir - an analogue of the purine nucleoside guanosine. These are incorporated into DNA - why they can induce toxicity if used inappropriately.
    • How acyclovir (an antiherpetic agent - aka a nucleoside analogue) works:
      • Transformed by phosphorylation into active state by viral enzymes - so the virus helps to activate the therapeutic agent
      • Greater affinity for viral than host enzymes - therefore less toxic - important; one of the problems with antiviral agents is that as well as affecting the viral DNA, they can also affect host DNA, so there's a limitation on the dose that can be used
      • Incorporates into viral DNA
      • Inhibits viral DNA synthesis
      • In the early stages, when there's more replication going on, it's going to be more effective
    • Pharmacokinetics of acyclovir (antiherpetic agent - aka a nucleoside analogue):
      • Aciclovir half-life is 2.5 hours (short)
      • Crosses the blood-brain barrier - given systemically
      • Excreted by the kidneys
      • Resistance is rare
      • Administration: may be prescribed topically (ointment - by dentist) or intravenously (in hospital)
    • Unwanted effects of acyclovir (antiherpetic agent - aka a nucleoside analogue):
      • Nausea and headaches
      • Transient burning sensation on application
    • Idoxuridine:
      • A thymidine analogue
      • Phosphorylated in cells and is incorporated into cellular and viral DNA
      • Unlike aciclovir it doesn't block DNA synthesis
      • Mainly used against DNA viruses and is too toxic for systemic use - can be used topically though
    • Zidovudine (AZT):
      • A thymidine analogue
      • Cytopathic against HIV-1
      • Mode of action:
      • Inhibits viral RNA-dependent DNA polymerase
      • Prevents further nucleotides from being incorporated into a growing strand of DNA
      • Action can be enhanced by aciclovir and interferon
      • Administration: orally or by continuous intravenous infusion
    • Zidovudine (AZT):
      • Pharmacokinetics:
      • Rapidly absorbed from GIT
      • Peak plasma concentration after 30-90 minutes
      • Metabolised in the liver and excreted via kidneys
      • Unwanted effects:
      • Anaemia
      • Granulocytopaenia
      • Regular blood count every 2 weeks
      • Main use = treatment of HIV and AIDS patients who are symptomatic
    • Reverse transcriptase inhibitors:
      • An RNA-dependent DNA polymerase inhibitor
      • They are nucleoside analogues - some of the newer drugs e.g. Nevirapine are non-nucleosides
    • Non-nucleoside analogues are used in the treatment of AIDS - eg nevirapine and delavirdine
    • Other antiviral agents:
      • Interferons - a group of cytokines
      • 3 main types: Alpha/Beta/Gamma
      • Glycoproteins produced by the body in response to a viral infection
      • Enhance the cytotoxic capacity of T-lymphocytes
    • Prions:
      • Not bacteria or virus but are infective agents
      • Contain no genetic material and are pure proteins
      • Can produce configurational changes in host protein
    • Prion diseases:
      • BSE - Bovine Spongiform Encephalitis (cattle)
      • Creutzfeldt-Jakob disease
      • Not possible to sterilise instruments - disposable used